Advanced Enzyme Technologies has informed that the Board of Directors at its meeting held on October 31, 2026 has approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026.
The above information is a part of company’s filings submitted to BSE.